AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

654.522

-0.062-0.01%

Number of Gainers:17

Number of Losers:7

Number of Flat:21

PE:- -

High:656.360

Open:654.803

Low:647.137

Close:654.584

Volume:38.01M

Turnover:113.41M

Market Cap:97.85B

Float Cap:94.78B

Loading ...

BRIEF-CSL Ltd Sees High Single-Digit NPAT Growth Beyond FY26

CSL Ltd Sees Continued Dividends and Multi-Year, on-Market Share Buybacks Beyond FY26

THOMSON REUTERS

CSL Ltd Sees Mid Single-Digit Revenue Growth Beyond FY26

THOMSON REUTERS

Immuron Ltd - Imm-529 Ind Approved by FDA

THOMSON REUTERS

Mesoblast To Meet With FDA Next Month To Discuss Rexlemestrocel-L And Opioid Cessation

Playing India... (not just at cricket)

Cynata Therapeutics Ltd-Cynata Receives $1.7M R&D Tax Incentive Refund

THOMSON REUTERS

ICBA Calls for Coinbase Bank Charter Denial, Coinbase Counters Saying Its Actions Are Bank Protectionism, Not Consumer Protection

BUZZ-ASX shares of Mesoblast jump on FDA meeting plans, Phase 3 study update

Orthocell Appoints Second Distributor in Canada for Nerve Repair Product

MT Newswires Live

Clinuvel Pharmaceuticals (ASX:CUV): Valuation Insights After SEC Review Delay and Share Price Dip

Simply Wall St.

BRIEF-Polynovo Discloses Contained Fire Event At Research And Development Facility

Polynovo Ltd - We Do Not Anticipate That Damage From Fire Will Impact Upon R&D Activities

THOMSON REUTERS

Polynovo Ltd - Fire Had No Effect on Company's Manufacturing Capacity or Inventory

THOMSON REUTERS

Polynovo Ltd - Building Was Unoccupied at Time, and No One Was Injured

THOMSON REUTERS

Polynovo Ltd - Contained Fire Event at R&D Facility

THOMSON REUTERS

Mayne Says FIRB Extends Deadline for Decision Regarding Proposed Acquisition by Cosette Pharmaceuticals

MT Newswires Live

Mayne Pharma Group Ltd-Update on Status of Firb Approval & Second Court Hearing

THOMSON REUTERS

Mayne Pharma Group Ltd - Firb Extends Deadline to 7 November, May Extend to 14 November

THOMSON REUTERS

Morgans’ top large-cap picks for November 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":654.5221,"timestamp":1762750799929,"preClose":654.584,"halted":0,"volume":38013710,"delay":0,"changeRate":-0.000095,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Post Close","change":-0.06189,"latestTime":"11-10 16:00:00 AEDT","open":654.80316,"high":656.3603,"low":647.13666,"amount":113407378,"amplitude":0.014091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1762815600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762729200000,1762750800000]],"turnoverRate":0.00146,"increases":18,"decrements":9,"flats":17,"marketCap":97850947101.5,"floatMarketCap":94779941098.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":656.3603,"amplitude":0.014091,"preClose":654.584,"low":647.13666,"latestPrice":654.5221,"volume":38013710,"delay":0,"open":654.80316,"prevYearClose":936.801,"prevWeekClose":654.584,"prevMonthClose":662.953,"prevQuarterClose":712.826,"fiveDayClose":650.95,"twentyDayClose":751.072,"sixtyDayClose":937.392,"secType":"PLATE","market":"AU","turnoverRate":0.00146,"marketCap":97850947101.5,"floatMarketCap":94779941098.625,"timestamp":1762750799929,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":17,"down":7,"flat":21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581749169","title":"BRIEF-CSL Ltd Sees High Single-Digit NPAT Growth Beyond FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2581749169","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581749169?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:27","pubTimestamp":1762331238,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Ltd Sees High Single-Digit NPAT Growth Beyond FY26Nov 5  - CSL Ltd CSL.AX:SEES MID SINGLE-DIGIT REVENUE GROWTH BEYOND FY26SEES HIGH SINGLE-DIGIT NPAT GROWTH BEYOND FY26SEES CONTINUED DIVIDENDS AND MULTI-YEAR, ON-MARKET SHARE BUYBACKS BEYOND FY26Further company coverage: CSL.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WG24R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7511","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2581749800","title":"CSL Ltd Sees Continued Dividends and Multi-Year,  on-Market Share Buybacks Beyond FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2581749800","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581749800?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:21","pubTimestamp":1762330867,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WG24R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7508","BK7511","BK7067","BK7501"],"gpt_icon":0},{"id":"2581498077","title":"CSL Ltd Sees Mid Single-Digit Revenue Growth Beyond FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2581498077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581498077?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:21","pubTimestamp":1762330867,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WG24R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7511","BK7508","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2581446716","title":"Immuron Ltd - Imm-529 Ind Approved by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2581446716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581446716?lang=en_us&edition=fundamental","pubTime":"2025-11-05 12:05","pubTimestamp":1762315530,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WG1TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2581679772","title":"Mesoblast To Meet With FDA Next Month To Discuss Rexlemestrocel-L And Opioid Cessation","url":"https://stock-news.laohu8.com/highlight/detail?id=2581679772","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581679772?lang=en_us&edition=fundamental","pubTime":"2025-11-05 09:44","pubTimestamp":1762307064,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Mesoblast Ltd ::*MESOBLAST TO MEET WITH FDA NEXT MONTH TO DISCUSS REXLEMESTROCEL-L AND OPIOID CESSATION*Further company coverage: MSB.AX* ((Reuters.Briefs@thomsonreuters.com;))  ((Re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nRSD9dg7YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MSB.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2581943577","title":"Playing India... (not just at cricket)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581943577","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581943577?lang=en_us&edition=fundamental","pubTime":"2025-11-05 09:23","pubTimestamp":1762305786,"startTime":"0","endTime":"0","summary":"As global investors shift their focus to resilient growth markets, India has become an attractive destination, and Australian companies are seizing the opportunity. From infrastructure and resources to telecom and healthcare, ASX-listed firms are steadily integrating themselves into India’s economic rise.Macquarie Group  has been a leader in infrastructure financing in India, supporting toll roads, renewable energy parks, and public-private partnerships. With India’s infrastructure spending expected to surpass USD $1.4 trillion by 2030, Macquarie’s significant investment in transport and energy assets positions it as a key player in the country’s growth story.BHP Group  continues to provide metallurgical coal and critical minerals to Indian steelmakers, while also exploring opportunities in copper and potash—key for India’s EV goals and agricultural needs. With India boosting domestic manufacturing and clean energy efforts, BHP’s resources align well with the country’s industrial prior","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/playing-india-not-just-at-cricket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/playing-india-not-just-at-cricket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["MQG.AU","BK7135","CSL.AU","BHP.AU","BK7507","BK7508","XJO.AU","BK7511","XKO.AU","TLS.AU","XAO.AU","BK7067","BK7501","BK7046","ANZ.AU","BK7095","BK7042"],"gpt_icon":0},{"id":"2581792930","title":"Cynata Therapeutics Ltd-Cynata Receives $1.7M R&D Tax Incentive Refund","url":"https://stock-news.laohu8.com/highlight/detail?id=2581792930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581792930?lang=en_us&edition=fundamental","pubTime":"2025-11-05 09:14","pubTimestamp":1762305248,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUE7KZHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CYP.AU","BK7508","BK7501","BK7067"],"gpt_icon":0},{"id":"2581581794","title":"ICBA Calls for Coinbase Bank Charter Denial, Coinbase Counters Saying Its Actions Are Bank Protectionism, Not Consumer Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2581581794","media":"Blockbeats","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581581794?lang=en_us&edition=fundamental","pubTime":"2025-11-05 08:40","pubTimestamp":1762303200,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 5th, the Independent Community Bankers of America  sent a letter to the Office of the Comptroller of the Currency , urging the rejection of Coinbase's subsidiary Coinbase National Trust Co.'s national trust bank charter application, citing that the application failed to meet statutory standards and if approved would set a dangerous precedent for the U.S. banking system.In response, Coinbase's Chief Legal Officer Paul Grewal stated: \"The ICBA opposes a regulated trust charter simply because you want cryptocurrency to remain unregulated. That is the ICBA position. This is yet another example of banking lobbyists seeking to undermine regulatory barriers to protect their own interests. From repealing laws to hold accountable to obstructing the issuance of trust charters, protectionism is not consumer protection.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/319149","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/319149","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU0477156797.USD","BK4596","COIN","LU0648000940.SGD","LU0130103400.USD","LU1861558580.USD","LU0175139822.USD","BK4112","LU0208291251.USD","LU1201861249.SGD","OCC","BK7508","BK4534","BK4020","LU0980610538.SGD","LU1861559042.SGD","LU0070302665.USD","OCC.AU","BK4559","BK4539","BK4554","BK4535","LU0130102774.USD","BK4588","LU0648001328.SGD","BK7067","LU1861220207.SGD","BK4600","BK4516","LU0130517989.USD","LU0320765489.SGD","LU1201861165.SGD","BK4551","BK4100","BK4585","BK4595","LU0211331839.USD","LU2360107671.USD","LU1861217088.USD","CHTR","LU0130518102.USD","LU0477156953.USD","LU0289960550.SGD"],"gpt_icon":1},{"id":"2581791230","title":"BUZZ-ASX shares of Mesoblast jump on FDA meeting plans, Phase 3 study update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581791230","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581791230?lang=en_us&edition=fundamental","pubTime":"2025-11-05 08:33","pubTimestamp":1762302792,"startTime":"0","endTime":"0","summary":"BUZZ-ASX shares of Mesoblast jump on FDA meeting plans, Phase 3 study update** ASX-listed shares of inflammatory disease drug maker Mesoblast MSB.AX rise as much as 2.3% to A$2.465, their biggest intra-day percentage gain since October 21** MSB says co will meet with U.S. Food & Drug Administration in early December to discuss data on opioid reduction ** Says co will also discuss cessation from its first Phase 3 study  of rexlemestrocel-L in patients with chronic low back pain ** Stock third-biggest percentage gainer in the S&P/ASX 200 Health care sub-index ** Stock currently up 1% at A$2.435** Stock down 22.3% this year, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL4N3WH01D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7067","BK7501","BK7508"],"gpt_icon":0},{"id":"2581679661","title":"Orthocell Appoints Second Distributor in Canada for Nerve Repair Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2581679661","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581679661?lang=en_us&edition=fundamental","pubTime":"2025-11-05 07:33","pubTimestamp":1762299215,"startTime":"0","endTime":"0","summary":"Orthocell  appointed a second Canadian distributor for its Remplir nerve repair product, according to a Wednesday Australian bourse filing.The firm granted exclusive distribution rights for the provinces of Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland to an Ontario-based distributor. Orthocell added that the appointment ensures its full coverage of the $75 million Canadian market.The first Canadian sales are expected in the December quarter, and the rollout in Canada will be managed by Orthocell's existing US-based marketing and medical education teams.Its shares fell 2% in recent trading on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OCC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2581752570","title":"Clinuvel Pharmaceuticals (ASX:CUV): Valuation Insights After SEC Review Delay and Share Price Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2581752570","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581752570?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:35","pubTimestamp":1762256123,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) shared that the ongoing U.S. Federal government shutdown is expected to slow the review and approval of its SEC filings. The company’s share price slipped following news of the delay.\nSee our latest analysis for Clinuvel Pharmaceuticals.\nClinuvel’s share price has steadily softened this year, with a 30-day share price return of -10.26% hinting at fading momentum. Ongoing SEC-related delays are adding to the pressure. The bigger picture shows a one-year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/clinuvel-pharmaceuticals-asxcuv-valuation-insights-after-sec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/clinuvel-pharmaceuticals-asxcuv-valuation-insights-after-sec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","CUV.AU"],"gpt_icon":0},{"id":"2580781195","title":"BRIEF-Polynovo Discloses Contained Fire Event At Research And Development Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2580781195","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580781195?lang=en_us&edition=fundamental","pubTime":"2025-11-04 18:16","pubTimestamp":1762251414,"startTime":"0","endTime":"0","summary":"BRIEF-Polynovo Discloses Contained Fire Event At Research And Development FacilityNov 4  - Polynovo Ltd PNV.AX:CONTAINED FIRE EVENT AT RESEARCH AND DEVELOPMENT FACILITYWE DO NOT ANTICIPATE THAT DAMAGE FROM FIRE WILL IMPACT UPON RESEARCH AND DEVELOPMENT ACTIVITIESFIRE AFFECTED ONLY A SMALL SECTION OF FACILITY AND WAS QUICKLY CONTAINEDBUILDING WAS UNOCCUPIED AT TIME, AND NO ONE WAS INJUREDFIRE HAD NO EFFECT ON COMPANY'S MANUFACTURING CAPACITY OR INVENTORYDO NOT ANTICIPATE INCIDENT WILL HAVE ANY IMPACT ON COMPANY'S SALESFurther company coverage: PNV.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WF2IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PNV.AU","BK7508","BK7126"],"gpt_icon":0},{"id":"2580620620","title":"Polynovo Ltd - We Do Not Anticipate That Damage From Fire Will Impact Upon R&D Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2580620620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580620620?lang=en_us&edition=fundamental","pubTime":"2025-11-04 14:25","pubTimestamp":1762237543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WF2IC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PNV.AU","BK7126"],"gpt_icon":0},{"id":"2580206209","title":"Polynovo Ltd - Fire Had No Effect on Company's Manufacturing Capacity or Inventory","url":"https://stock-news.laohu8.com/highlight/detail?id=2580206209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580206209?lang=en_us&edition=fundamental","pubTime":"2025-11-04 14:25","pubTimestamp":1762237543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WF2IC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PNV.AU","BK7126","BK7508"],"gpt_icon":0},{"id":"2580206203","title":"Polynovo Ltd - Building Was Unoccupied at Time, and No One Was Injured","url":"https://stock-news.laohu8.com/highlight/detail?id=2580206203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580206203?lang=en_us&edition=fundamental","pubTime":"2025-11-04 14:25","pubTimestamp":1762237543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WF2IC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PNV.AU","BK7508","BK7126"],"gpt_icon":0},{"id":"2580206201","title":"Polynovo Ltd - Contained Fire Event at R&D Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2580206201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580206201?lang=en_us&edition=fundamental","pubTime":"2025-11-04 14:25","pubTimestamp":1762237543,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WF2IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PNV.AU","BK7126"],"gpt_icon":0},{"id":"2580208559","title":"Mayne Says FIRB Extends Deadline for Decision Regarding Proposed Acquisition by Cosette Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2580208559","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580208559?lang=en_us&edition=fundamental","pubTime":"2025-11-04 12:52","pubTimestamp":1762231925,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said the Foreign Investment Review Board  has extended the statutory deadline for a decision regarding the Group's proposed acquisition by Cosette Pharmaceuticals through a scheme of arrangement to Nov. 7, according to a Tuesday filing with the Australian bourse.The FIRB also indicated that the deadline may be extended until Nov. 14 if necessary, while the Second Court hearing is set for Nov. 20, the filing said.If the board's decision is received before Nov. 14, the company may ask the Court to bring forward the date of the Second Court hearing, the filing added.Shareholders can oppose the scheme by filing a notice of appearance and affidavit at least one day before the hearing, the company said.Shares of the company rose 1% in recent Tuesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2580627713","title":"Mayne Pharma Group Ltd-Update on Status of Firb Approval & Second Court Hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580627713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580627713?lang=en_us&edition=fundamental","pubTime":"2025-11-04 12:01","pubTimestamp":1762228860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUEB3S82:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2580416277","title":"Mayne Pharma Group Ltd - Firb Extends Deadline to 7 November, May Extend to 14 November","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416277?lang=en_us&edition=fundamental","pubTime":"2025-11-04 12:01","pubTimestamp":1762228860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUEB3S82:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2580768932","title":"Morgans’ top large-cap picks for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580768932","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580768932?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:35","pubTimestamp":1762223757,"startTime":"0","endTime":"0","summary":"After two consecutive years of aggregate earnings decline, the ASX 200 is. forecast to return to growth, with earnings expected to rise 5.7% in FY26 and. we see this as limiting multiple expansion rather than signalling downside price. risk. But concentration risk and ongoing macroeconomic tremors will continue to. see significant stock divergence, and investors will need to remain nimble and on. Although the financial year-end of most Australian businesses is the end of June,many important listed companies report to the end of March and September.This month, we update our large-cap Best Ideas, adding Aristocrat and removing Treasury Wine Estates, WiseTech and Light & Wonder.CSL is looking to simplify operations and reduce complexity to enhance agility and performance. CSL will hold a Capital Markets Day in the US from November 4–6, 2025, to provide further details on its strategy, this will be important to help investors regain confidence.oil prices, if any volatility were to unfold i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/morgans-top-large-cap-picks-for-november-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/morgans-top-large-cap-picks-for-november-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU1244550494.USD","LU2237443382.USD","BK7097","CSL.AU","TWE.AU","NST.AU","BK7501","LU2237443978.SGD","BK7505","LU0310799852.SGD","LU0211328371.USD","RMD.AU","BK4532","LU2237443622.USD","BK7508","BK7007","LU1267930490.SGD","BK4504","BK7506","LU0823411888.USD","LNW.AU","BK7511","TGT","LU1244550221.USD","ALL.AU","LU0310800965.SGD","BK7063","BK4155","BK7155","LU0128525689.USD","BK7503","LU1267930227.SGD","LU1244550577.SGD","LU0052756011.USD","BK4533","LU0211327993.USD","AMC.AU","BK7099","BK4596","BK4114","GMG.AU","BK4597","BK7078","WTC.AU","BK4588","BK4585","BK7067","WDS.AU","BK7016","BK7142"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":3,"totalSize":171,"code":"91000000","status":"200"}]}}